GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
42.95 -0.47  -1.08% NYSE Sep 26, 16:44 Delayed 2m USD

GlaxoSmithKline Cash from Investing (TTM):

-2.259B for June 30, 2016
View 4,000+ financial data types
Browse...
View Full Chart

GlaxoSmithKline Cash from Investing (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical Cash from Investing (TTM) Data

View and export this data going back to 1985. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2016 -2.259B
March 31, 2016 -2.476B
Dec. 31, 2015 9.226B
Sept. 30, 2015 9.403B
June 30, 2015 9.197B
March 31, 2015 9.522B
Dec. 31, 2014 -1.777B
Sept. 30, 2014 1.675B
June 30, 2014 1.202B
March 31, 2014 730.11M
Dec. 31, 2013 819.84M
Sept. 30, 2013 -2.432B
June 30, 2013 -5.407B
March 31, 2013 -4.858B
Dec. 31, 2012 -4.169B
Sept. 30, 2012 -4.506B
June 30, 2012 -1.085B
March 31, 2012 -1.291B
Dec. 31, 2011 -179.59M
Sept. 30, 2011 -277.50M
June 30, 2011 -685.68M
March 31, 2011 -1.037B
Dec. 31, 2010 -2.880B
Sept. 30, 2010 -2.905B
June 30, 2010 -6.128B
   
March 31, 2010 -5.834B
Dec. 31, 2009 -6.286B
Sept. 30, 2009 -6.838B
June 30, 2009 -3.247B
March 31, 2009 -2.588B
Dec. 31, 2008 -2.125B
Sept. 30, 2008 -3.434B
June 30, 2008 -3.766B
March 31, 2008 -4.595B
Dec. 31, 2007 -6.028B
Sept. 30, 2007 -4.565B
June 30, 2007 -4.680B
March 31, 2007 -4.434B
Dec. 31, 2006 -2.803B
Sept. 30, 2006 -3.810B
June 30, 2006 -3.367B
March 31, 2006 -3.428B
Dec. 31, 2005 -3.020B
Sept. 30, 2005 -1.044B
June 30, 2005 -1.375B
March 31, 2005 -1.307B
Dec. 31, 2004 -1.686B
Sept. 30, 2004 -2.089B
June 30, 2004 -1.697B
March 31, 2004 -1.573B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Advertisement

GSK Cash from Investing (TTM) Benchmarks

Companies
Pfizer -7.79B
Johnson & Johnson -2.607B
Eli Lilly -1.483B

GSK Cash from Investing (TTM) Range, Past 5 Years

Minimum -5.407B Jun 2013
Maximum 9.522B Mar 2015
Average 553.01M

GSK Cash from Investing (TTM) Excel Add-In Codes

  • Metric Code: cash_investing_ttm
  • Latest data point: =YCP("GSK", "cash_investing_ttm")
  • Last 5 data points: =YCS("GSK", "cash_investing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.